(6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one

C36H67NO10 — CID 142203921

IUPAC(6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one
SMILESCCC1OC(=O)C(C)C(O[C@H]2CC(C)[C@@H](O)C(C)O2)C(C)[C@](C)(OC2CC(N(C)C)CC(C)O2)C(C)CC[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C36H67NO10/c1-13-28-35(9,42)33(40)22(5)27(38)15-14-20(3)36(10,47-30-18-26(37(11)12)17-21(4)43-30)24(7)32(23(6)34(41)45-28)46-29-16-19(2)31(39)25(8)44-29/h19-33,38-40,42H,13-18H2,1-12H3/t19?,20?,21?,22-,23?,24?,25?,26?,27-,28?,29-,30?,31+,32?,33+,35+,36+/m0/s1
InChIKeyRYSBREYBNFFRSX-DYUZPTKSSA-N
MW673.93 g/mol
LogP3.87
Rot. Bonds6

About (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one

(6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one (PubChem CID 142203921) has the molecular formula C36H67NO10 and a molecular weight of 673.93 g/mol. Its IUPAC name is (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one.

Molecular Properties

Compound Name(6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one
PubChem CID142203921
Molecular FormulaC36H67NO10
Molecular Weight673.93 g/mol
Exact Mass673.48
IUPAC Name(6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one
SMILESCCC1OC(=O)C(C)C(O[C@H]2CC(C)[C@@H](O)C(C)O2)C(C)[C@](C)(OC2CC(N(C)C)CC(C)O2)C(C)CC[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C36H67NO10/c1-13-28-35(9,42)33(40)22(5)27(38)15-14-20(3)36(10,47-30-18-26(37(11)12)17-21(4)43-30)24(7)32(23(6)34(41)45-28)46-29-16-19(2)31(39)25(8)44-29/h19-33,38-40,42H,13-18H2,1-12H3/t19?,20?,21?,22-,23?,24?,25?,26?,27-,28?,29-,30?,31+,32?,33+,35+,36+/m0/s1
InChIKeyRYSBREYBNFFRSX-DYUZPTKSSA-N
XLogP3.87
TPSA147.38 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms47
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500673.93
LogP ≤ 53.87
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Analyze (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one?
The IUPAC name of (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one (CID 142203921) is (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one.
What is the SMILES notation for (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one?
The canonical SMILES for (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one is CCC1OC(=O)C(C)C(O[C@H]2CC(C)[C@@H](O)C(C)O2)C(C)[C@](C)(OC2CC(N(C)C)CC(C)O2)C(C)CC[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O.
What is the InChIKey of (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one?
The InChIKey is RYSBREYBNFFRSX-DYUZPTKSSA-N. The full InChI is InChI=1S/C36H67NO10/c1-13-28-35(9,42)33(40)22(5)27(38)15-14-20(3)36(10,47-30-18-26(37(11)12)17-21(4)43-30)24(7)32(23(6)34(41)45-28)46-29-16-19(2)31(39)25(8)44-29/h19-33,38-40,42H,13-18H2,1-12H3/t19?,20?,21?,22-,23?,24?,25?,26?,27-,28?,29-,30?,31+,32?,33+,35+,36+/m0/s1.
What are the key properties of (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one?
(6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one has a molecular weight of 673.93 g/mol, XLogP of 3.87, 6 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (6R,10S,11S,12R,13S)-6-[4-(dimethylamino)-6-methyloxan-2-yl]oxy-14-ethyl-10,12,13-trihydroxy-4-[(2R,5R)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,11,13-hexamethyl-oxacyclotetradecan-2-one is sourced from PubChem (CID 142203921), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).